AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (September 12, 2006). doi:10.1152/ajprenal.00415.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/F285    most recent
00415.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, L.
Right arrow Articles by Zaidi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, L.
Right arrow Articles by Zaidi, M.
Submitted on October 20, 2005
Accepted on July 10, 2006

Evidence that calcineurin is required for the genesis of bone resorbing osteoclasts

Li Sun1, Yuanzhen Peng1, Neeha Zaidi1, Ling-Ling Zhu1, Jameel Iqbal1, Kosj Yamoah1, Xin Wang2, Peng Liu1, Etsuko Abe1, Baljit S Moonga1, Solomon Epstein1, and Mone Zaidi1*

1 Medicine and Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, New York, United States
2 Endocrinology, Mount Sinai, New York, New York, United States

* To whom correspondence should be addressed. E-mail: mone.zaidi{at}mssm.edu.

Here we demonstrate that the Ca2+/calmodulin-sensitive phosphatase calcineurin is a necessary downstream mediator for osteoclast differentiation. Using quantitative PCR (qPCR), we detected all calcineurin isoforms, namely A{alpha}, A{beta}, A{gamma} (catalytic) and B1 and B2 (regulatory) in osteoclast precursor RAW-C3 cells. We found that while the expression of these isoforms remained relatively unchanged during osteoclast differentiation, there was a profound increase in the expression of their primary substrate for calcineurin, NFATc1. For gain-of-function studies, we incubated osteoclast precursors for 10 minutes with a calcineurin fusion protein, TAT-calcineurin A{alpha}, this resulted in its receptor-less influx into >90% of the precursor cells. A marked increase in the expression of the osteoclast differentiation markers tartrate-resistant acid phosphatase (TRAP) and integrin {beta}3 followed. In addition, the expression of NFATc1, as well as the alternative substrate for calcineurin, I{kappa}B{alpha}, was enhanced significantly. Likewise, transfection with constitutively active NFAT (NFATca) resulted in an increased expression of both TRAP and {beta}3. In parallel loss-of-function studies, transfection with dominant-negative NFAT (NFATdnnot only inhibited osteoclast formation, but also reversed the induction of NFATc1, TRAP and {beta}3 by TAT-calcineurin A{alpha}. The expression of these markers was also inhibited by calcineurin A{alpha} U1 snRNA. Consistent with these observations, we also observed a reduction in osteoclastogenesis in calcineurin A{alpha}-\- cells, as well as in osteoclast precursors treated with the calcineurin inhibitors, cyclosporine A and FK506. Together the gain- and loss-of-function experiments establish that calcineurin A{alpha} is necessary for osteoclast formation from its precursor, and that this occurs via an NFATc1-dependent mechanism.




This article has been cited by other articles:


Home page
Genes Dev.Home page
S. Yang and Y.-P. Li
RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation
Genes & Dev., July 15, 2007; 21(14): 1803 - 1816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.